Peter Djali

Peter Djali

Company: LUMICKS

Job title: Manager, Cell Avidity/Immuno-Oncology Division


Tumour-Effector Cell Avidity is a Key Driver for Cellular Therapy Efficacy 11:30 am

Avidity is a new key parameter for predicting T-cell function Avidity data strongly correlates to in vitro functional assays and preclinical mouse studies The z-Movi Cell Avidity Analyzer measures the avidity of lymphocytes with tumour cells at the single-cell level using an extremely quick and easy workflowRead more

day: Day 1 - Track A - Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.